First, in the week ending December 31, 2022 (week 52), seasonal influenza activity remained high but continued to decline in most areas.
In terms of viruses, 15.0% of clinical laboratory specimens tested positive for influenza during week 52. The majority of positive specimens were influenza A(H3N2) viruses.
Virus characterization indicated that the currently circulating influenza viruses are similar to the ones included in this season's influenza vaccine.
Outpatient respiratory illness visits accounted for 5.4% of patient visits, which is above the national baseline of 2.5%. All 10 HHS regions reported rates above their respective baselines.
Long-term care facilities reported 5.5% of facilities having at least one influenza-positive test among residents during week 52.
FluSurv-NET reported a cumulative hospitalization rate of 48.6 per 100,000 population, which is higher than previous seasons but lower than end-of-season rates for most seasons.
For mortality, 12.8% of deaths occurring during week 52 were attributed to pneumonia, influenza, or COVID-19, above the epidemic threshold of 6.9%.
Thirteen influenza-associated pediatric deaths were reported during week 52, with a total of 74 reported for the season.
Overall, the data suggest that influenza activity is declining but remains relatively high, and vaccination and antiviral treatment are important preventive measures.